hGLP-1R and mGlp-1r expression assessed in brain, liver and lung of WT and genO-hGLP1R mice by RT-qPCR.
Blood glucose was monitored every 30 minutes.
DNG efficiently decreases circulating glucose in genO‑hGLP-1R model.
13 genO‑hGLP-1R or WT mice were injected with Danuglipron or vehicle and 15 minutes later administered 40% dextrose at 2g/kg. (A) Blood glucose was measured via tail nick using a handheld glucometer at the indicated timepoints. (B) Blood samples were collected to measure plasma insulin by ELISA at the indicated timepoints.